Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Strategy to improve the bioavailability of anthelmintic agents

Aug. 24, 1998

Fluoroquinolone antibacterial available for licensing from Dong Wha

Aug. 24, 1998

Fungal enzyme inhibitors synthesized at Nippon Roche

Aug. 24, 1998

New indication approved for AmBisome in the U.K.

Aug. 24, 1998

Hoechst describes novel antibiotic feglymycin

Aug. 21, 1998

Glaxo Wellcome synthesizes improved carbapenem antibacterials

Aug. 20, 1998

U.S. patent issued for MediChem Research's antiviral biflavanoids

Aug. 19, 1998

Medivir synthesizes esters of antiviral nucleosides with improved bioavailability

Aug. 19, 1998

Antifungal agents disclosed by Sankyo in patent literature

Aug. 19, 1998

Potent anti-HSV-1 activity demonstrated with BILD-1633-SE in vivo

Aug. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D
BioWorld Science
Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.